First Trust · 2006-06-19 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$64.7M | — | — | $2.81B | 每日估算 |
| 2026-07-30 | +$61.3M | — | — | $2.85B | 每日估算 |
| 2026-07-29 | -$59.4M | — | — | $2.80B | 每日估算 |
| 2026-07-28 | +$18.7M | — | — | $2.81B | 每日估算 |
| 2026-07-27 | +$17.2M | — | — | $2.81B |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
MRNA Moderna Inc COM | EC | 2,351,289 | $119.4M | 5.26% |
UTHR United Therapeutics Corporation COM | EC | 166,849 | $98.9M | 4.36% |
ALKS Alkermes PLC SHS | EC | 2,719,064 | $96.1M | 4.24% |
GILD Gilead Sciences Inc. COM |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| 每日估算 |
| 2026-07-26 | +$16.2M | — | — | $2.81B | 每日估算 |
| 2026-07-25 | +$16.2M | — | — | $2.81B | 每日估算 |
| 2026-03-31 | -$18.5M | $30.8M | $49.3M | $2.27B | SEC 月度 |
| 2026-02-28 | +$21.0M | $41.9M | $20.9M | — | SEC 月度 |
| 2026-01-31 | +$1.06B | $1.12B | $54.3M | — | SEC 月度 |
| EC |
| 665,992 |
| $92.8M |
| 4.09% |
AXSM Axsome Therapeutics Inc. COM | EC | 521,878 | $88.2M | 3.89% |
AMGN Amgen Inc. COM | EC | 247,283 | $87.0M | 3.83% |
CORT Corcept Therapeutics Inc. COM | EC | 2,150,626 | $86.7M | 3.82% |
KRYS Krystal Biotech Inc COM | EC | 308,504 | $79.7M | 3.51% |
BIIB Biogen Inc COM | EC | 429,853 | $78.8M | 3.47% |
EXEL Exelixis, Inc. COM | EC | 1,831,270 | $78.5M | 3.46% |
NBIX Neurocrine Biosciences Inc COM | EC | 593,926 | $78.2M | 3.45% |
REGN Regeneron Pharmaceuticals, Inc. COM | EC | 101,249 | $78.2M | 3.45% |
VRTX Vertex Pharmaceuticals Incorporated COM | EC | 173,834 | $77.6M | 3.42% |
BMRN Biomarin Pharmaceutical Inc. COM | EC | 1,368,040 | $77.3M | 3.40% |
ARGX Argenx SE SPONSORED ADR | EC | 102,325 | $74.7M | 3.29% |
SRPT Sarepta Therapeutics Inc COM | EC | 3,384,344 | $73.6M | 3.24% |
HALO Halozyme Therapeutics Inc COM | EC | 1,112,843 | $71.9M | 3.17% |
BNTX BioNTech SE SPONSORED ADS | EC | 807,711 | $71.8M | 3.16% |
INCY Incyte Corporation. COM | EC | 754,631 | $71.0M | 3.13% |
ONC BeOne Medicines Ltd. SPONSORED ADS | EC | 238,672 | $70.9M | 3.12% |
ILMN Illumina Inc COM | EC | 571,731 | $70.5M | 3.10% |
NTRA Natera Inc. COM | EC | 344,198 | $68.8M | 3.03% |
ACAD Acadia Pharmaceuticals Inc COM | EC | 3,011,495 | $67.0M | 2.95% |
ALNY Alnylam Pharmaceuticals Inc. COM | EC | 202,492 | $67.0M | 2.95% |
TECH Bio-Techne Corp COM | EC | 1,227,575 | $64.2M | 2.83% |
GMAB Genmab As SPONSORED ADS | EC | 2,354,019 | $63.2M | 2.78% |
VCYT Veracyte Inc COM | EC | 1,918,341 | $61.8M | 2.72% |
RGEN Repligen Corporation COM | EC | 483,433 | $57.0M | 2.51% |
BRKR Bruker Corporation COM | EC | 1,480,923 | $53.5M | 2.36% |
NEO Neogenomics Inc COM NEW | EC | 6,128,278 | $45.5M | 2.00% |
MISXX Dreyfus Government Cash Management Funds SH BEN INT | STIV | 1,413,994 | $1.4M | 0.06% |
DAIWA CAPITAL MARKETS AMERICA INC DAIWA CAPITAL MARKETS AMERICA INC | RA | 188,488 | $188,488 | 0.01% |